Global Gastrointestinal Stromal Tumor (GIST) Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Gastrointestinal Stromal Tumor (GIST) Drug

• 1.1 Definition of Gastrointestinal Stromal Tumor (GIST) Drug
• 1.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
  • 1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Amcasertib
  • 1.2.3 Anagrelide hydrochloride CR
  • 1.2.4 APG-1351
  • 1.2.5 Binimetinib
  • 1.2.6 Others
• 1.3 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Applications
  • 1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Overall Market
  • 1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2014-2025)
  • 1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production (2014-2025)
  • 1.4.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
  • 1.4.5 China Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
  • 1.4.8 India Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
• 2.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
• 2.4 Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug

3 Development and Manufacturing Plants Analysis of Gastrointestinal Stromal Tumor (GIST) Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Gastrointestinal Stromal Tumor (GIST) Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Gastrointestinal Stromal Tumor (GIST) Drug Production and Capacity Analysis
• 4.2 Gastrointestinal Stromal Tumor (GIST) Drug Revenue Analysis
• 4.3 Gastrointestinal Stromal Tumor (GIST) Drug Price Analysis
• 4.4 Market Concentration Degree

5 Gastrointestinal Stromal Tumor (GIST) Drug Regional Market Analysis

• 5.1 Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions
  • 5.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions
  • 5.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions
• 5.2 Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions
• 5.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
  • 5.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production
  • 5.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
• 5.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
  • 5.4.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production
  • 5.4.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
• 5.5 China Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
  • 5.5.1 China Gastrointestinal Stromal Tumor (GIST) Drug Production
  • 5.5.2 China Gastrointestinal Stromal Tumor (GIST) Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
• 5.6 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
  • 5.6.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production
  • 5.6.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
• 5.7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
  • 5.7.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production
  • 5.7.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
• 5.8 India Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
  • 5.8.1 India Gastrointestinal Stromal Tumor (GIST) Drug Production
  • 5.8.2 India Gastrointestinal Stromal Tumor (GIST) Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Gastrointestinal Stromal Tumor (GIST) Drug Import and Export

6 Gastrointestinal Stromal Tumor (GIST) Drug Segment Market Analysis (by Type)

• 6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Type
• 6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type
• 6.3 Gastrointestinal Stromal Tumor (GIST) Drug Price by Type

7 Gastrointestinal Stromal Tumor (GIST) Drug Segment Market Analysis (by Application)

• 7.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Application
• 7.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Application (2014-2019)

8 Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers Analysis

• 8.1 Ariad Pharmaceuticals, Inc.
  • 8.1.1 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.1.2 Ariad Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Arog Pharmaceuticals, Inc.
  • 8.2.1 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.2.2 Arog Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Array BioPharma Inc.
  • 8.3.1 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.3.2 Array BioPharma Inc. Product Introduction, Application and Specification
  • 8.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Astex Pharmaceuticals, Inc.
  • 8.4.1 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.4.2 Astex Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Blueprint Medicines Corporation
  • 8.5.1 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.5.2 Blueprint Medicines Corporation Product Introduction, Application and Specification
  • 8.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Boston Biomedical, Inc.
  • 8.6.1 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.6.2 Boston Biomedical, Inc. Product Introduction, Application and Specification
  • 8.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Calithera Biosciences, Inc.
  • 8.7.1 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.7.2 Calithera Biosciences, Inc. Product Introduction, Application and Specification
  • 8.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Chipscreen Biosciences Ltd
  • 8.8.1 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.8.2 Chipscreen Biosciences Ltd Product Introduction, Application and Specification
  • 8.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Deciphera Pharmaceuticals, LLC
  • 8.9.1 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.9.2 Deciphera Pharmaceuticals, LLC Product Introduction, Application and Specification
  • 8.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 F. Hoffmann-La Roche Ltd.
  • 8.10.1 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
  • 8.10.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
  • 8.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Horizon Pharma Plc
• 8.12 Immunicum AB
• 8.13 Jiangsu Hengrui Medicine Co., Ltd.
• 8.14 Kolltan Pharmaceuticals, Inc.
• 8.15 Natco Pharma Limited
• 8.16 Nerviano Medical Sciences S.r.l.
• 8.17 Novartis AG
• 8.18 Omeros Corporation

9 Development Trend of Analysis of Gastrointestinal Stromal Tumor (GIST) Drug Market

• 9.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Trend Analysis
  • 9.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Gastrointestinal Stromal Tumor (GIST) Drug Regional Market Trend
  • 9.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
  • 9.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
  • 9.2.3 China Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
  • 9.2.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
  • 9.2.6 India Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
• 9.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Trend (Product Type)
• 9.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List